Cargando…
Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
In order to explore the function of inhibiting the immune effect, the relationship between programmed death receptor 1 (PD-1) carrelizumab in the treatment of hepatocellular carcinoma-induced scleritis and T cell activation is investigated. A total of 120 patients with primary liver cancer treated i...
Autores principales: | Yuan, Yazhen, Pan, Shuaixi, Zou, Changpeng, Guo, Yan, Zhang, Changwang, Zheng, Zheng, Wu, Ninghan, Li, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467714/ https://www.ncbi.nlm.nih.gov/pubmed/36118947 http://dx.doi.org/10.1155/2022/4853481 |
Ejemplares similares
-
Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab
por: Imaging, Contrast Media & Molecular
Publicado: (2023) -
Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report
por: Liu, Liang, et al.
Publicado: (2021) -
Refractory necrotizing scleritis successfully treated with adalimumab
por: Lawuyi, Lola E., et al.
Publicado: (2016) -
Prognostic impact of sarcopenia in patients with hepatocellular
carcinoma treated with PD-1 inhibitor
por: Guo, Yusheng, et al.
Publicado: (2022) -
Anterior scleritis treated with systemic corticosteroids in Chikungunya infection
por: Cruz, João Carlos Gonçalves, et al.
Publicado: (2022)